These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 21166160

  • 21. p42/p44 mitogen-activated protein kinases inhibit atrial natriuretic peptide mRNA transcription in gp130-mediated hypertrophic ventricular myocytes.
    Dong ZL, Wang Y, Li TF, Zheng SJ, Kong YQ, Lan YL, Guo JL, Fu SG.
    Asian Pac J Trop Med; 2014 Mar; 7(3):216-20. PubMed ID: 24507643
    [Abstract] [Full Text] [Related]

  • 22. Hyperoside Protects Against Pressure Overload-Induced Cardiac Remodeling via the AKT Signaling Pathway.
    Wang X, Liu Y, Xiao L, Li L, Zhao X, Yang L, Chen N, Gao L, Zhang J.
    Cell Physiol Biochem; 2018 Mar; 51(2):827-841. PubMed ID: 30466089
    [Abstract] [Full Text] [Related]

  • 23. Quercetin inhibits left ventricular hypertrophy in spontaneously hypertensive rats and inhibits angiotensin II-induced H9C2 cells hypertrophy by enhancing PPAR-γ expression and suppressing AP-1 activity.
    Yan L, Zhang JD, Wang B, Lv YJ, Jiang H, Liu GL, Qiao Y, Ren M, Guo XF.
    PLoS One; 2013 Mar; 8(9):e72548. PubMed ID: 24039778
    [Abstract] [Full Text] [Related]

  • 24. Telmisartan suppresses cardiac hypertrophy by inhibiting cardiomyocyte apoptosis via the NFAT/ANP/BNP signaling pathway.
    Li X, Lan Y, Wang Y, Nie M, Lu Y, Zhao E.
    Mol Med Rep; 2017 May; 15(5):2574-2582. PubMed ID: 28447738
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The Effects of Dracocephalum Heterophyllum Benth Flavonoid on Hypertrophic Cardiomyocytes Induced by Angiotensin II in Rats.
    Jiang H, Zhang C, He W.
    Med Sci Monit; 2018 Sep 10; 24():6322-6330. PubMed ID: 30199522
    [Abstract] [Full Text] [Related]

  • 27. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload.
    Nakagawa O, Ogawa Y, Itoh H, Suga S, Komatsu Y, Kishimoto I, Nishino K, Yoshimasa T, Nakao K.
    J Clin Invest; 1995 Sep 10; 96(3):1280-7. PubMed ID: 7657802
    [Abstract] [Full Text] [Related]

  • 28. Pressure overload-induced cardiac hypertrophy response requires janus kinase 2-histone deacetylase 2 signaling.
    Ying H, Xu MC, Tan JH, Shen JH, Wang H, Zhang DF.
    Int J Mol Sci; 2014 Nov 05; 15(11):20240-53. PubMed ID: 25380525
    [Abstract] [Full Text] [Related]

  • 29. Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes.
    Li H, Shi S, Sun YH, Zhao YJ, Li QF, Li HZ, Wang R, Xu CQ.
    Clin Exp Pharmacol Physiol; 2009 Mar 05; 36(3):312-8. PubMed ID: 18986329
    [Abstract] [Full Text] [Related]

  • 30. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
    Liao Y, Asakura M, Takashima S, Ogai A, Asano Y, Shintani Y, Minamino T, Asanuma H, Sanada S, Kim J, Kitamura S, Tomoike H, Hori M, Kitakaze M.
    Circulation; 2004 Aug 10; 110(6):692-9. PubMed ID: 15262839
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
    Hilfiker-Kleiner D, Hilfiker A, Castellazzi M, Wollert KC, Trautwein C, Schunkert H, Drexler H.
    Cardiovasc Res; 2006 Jul 01; 71(1):108-17. PubMed ID: 16690042
    [Abstract] [Full Text] [Related]

  • 34. Atrial natriuretic peptide inhibits cardiomyocyte hypertrophy through mitogen-activated protein kinase phosphatase-1.
    Hayashi D, Kudoh S, Shiojima I, Zou Y, Harada K, Shimoyama M, Imai Y, Monzen K, Yamazaki T, Yazaki Y, Nagai R, Komuro I.
    Biochem Biophys Res Commun; 2004 Sep 10; 322(1):310-9. PubMed ID: 15313208
    [Abstract] [Full Text] [Related]

  • 35. AdipoRon prevents l-thyroxine or isoproterenol-induced cardiac hypertrophy through regulating the AMPK-related pathway.
    Hu X, Ou-Yang Q, Wang L, Li T, Xie X, Liu J.
    Acta Biochim Biophys Sin (Shanghai); 2019 Jan 01; 51(1):20-30. PubMed ID: 30566571
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. An adenosine A1 agonist 2-chloro-N6 cyclopentyladenosine inhibits the angiotensin II-induced cardiomyocyte hypertrophy through the calcineurin pathway.
    Zhang X, Xia J, Qian D, Wang Y, Lin Y, Huang X, Tan J.
    Cardiology; 2014 Jan 01; 129(3):153-62. PubMed ID: 25277512
    [Abstract] [Full Text] [Related]

  • 38. Simvastatin prevents cardiac hypertrophy in vitro and in vivo via JAK/STAT pathway.
    Liu J, Shen Q, Wu Y.
    Life Sci; 2008 May 07; 82(19-20):991-6. PubMed ID: 18400235
    [Abstract] [Full Text] [Related]

  • 39. Cardiac hypertrophy-related pathways in obesity.
    Chen WK, Yeh YL, Lin YM, Lin JY, Tzang BS, Lin JA, Yang AL, Wu FL, Tsai FJ, Cheng SM, Huang CY, Lee SD.
    Chin J Physiol; 2014 Jun 30; 57(3):111-20. PubMed ID: 24826779
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.